Partner Fund Management »

Eupraxia Pharmaceuticals shares owned by Partner Fund Management

Quarter-by-quarter ownership of Eupraxia Pharmaceuticals (EPRX) shares owned by Partner Fund Management from 13F filings

Historical chart of Partner Fund Management investment in Eupraxia Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Eupraxia Pharmaceuticals held by Partner Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eupraxia Pharmaceuticals by Partner Fund Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $3.9M 541k 7.24

More positions owned by Partner Fund Management

Tenet Healthcare Corp Com New (THC)
United Therapeutics Corporation (UTHR)
Eli Lilly & Co. (LLY)
Spdr Series Trust State Street Spd Put Option (XBI)
Penumbra (PEN)
Axsome Therapeutics (AXSM)
Ascendis Pharma A/s Sponsored Adr (ASND)
Select Sector Spdr Tr State Street Hea Call Option (XLV)
Jazz Pharmaceuticals Shs Usd (JAZZ)
Neurocrine Biosciences (NBIX)
Glaukos (GKOS)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Inhibrx Biosciences (INBX)
Edwards Lifesciences (EW)
Bridgebio Pharma (BBIO)

View all positions for Partner Fund Management

Top funds holding Eupraxia Pharmaceuticals

Beutel, Goodman & Company
Balyasny Asset Management
Vivo Capital
Scotia Capital
Ikarian Capital
Dr. Jeffrey R. Jay, M.D.
Point72 Asset Management
UBS Group
Redmile Group
Rubric Capital Management
Squadron Capital Management
Ally Bridge Group
Partner Fund Management
Ameriprise Financial
Woodline Partners

View all funds holding Eupraxia Pharmaceuticals